Expected Impact:
Expected Impacts
Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to:
- Achieve SDG3 'Ensure healthy lives and promote well-being for all at all ages' in sub-Saharan African (SSA) countries;
- Enable the implementation of the short- and medium-term actions foreseen by the AU EU Innovation Agenda (adopted in July 2023) in the area of public health and the EU Global Health Strategy (November 2022);
- Improve equitable access to a full range of essential health services from health promotion to disease prevention and affordable quality treatment, rehabilitation and palliative care to fight communicable diseases;
- Expand partnerships based on equal footing, co-ownership, mutual interest and strategic priorities;
- Enhance sustainable global scientific collaboration in health research and international cooperation across sub-Saharan Africa.
- Improve opportunities for training of researchers and healthcare professionals in sub-Saharan Africa.
Project results are expected to contribute to the following outcomes:
- Foster the culture of pharmaceutical innovation and entrepreneurship in sub-Saharan Africa;
- Increase the number of skilled clinical researchers and innovators in sub-Saharan Africa;
- Promote the career development and retention of skilled personnel in sub-Saharan Africa;
- Strengthen sub-Saharan African countries clinical human capital base in Research and Innovation (R&I);
- Enhance talent retention, knowledge circulation and uptake across the research